Barry E. Greene, President and COO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 22,822 shares at $30.00 ($685K) on 2013-05-28, disclosed to the SEC on 2013-05-30.
Scheduled sale ($685k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 7,894 | $237K | 34.6% |
| 2 | $30.00 | 14,928 | $448K | 65.4% |
| Total | $30.00 avg | 22,822 | $685K | 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |